Tata Capital Q1 FY27 Results Analysis: PAT Surges 56%, NIM Expands 309 bps (TATACAP)

CompoundingAI Research Updated July 28, 2026 2 min read
Positive

Tata Capital Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 8,821.93 Cr (+15.10% YoY) and PAT growth of +56.32% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateJuly 28, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 8,821.93 Cr (+15.10% YoY)
PAT (Q1)Rs. 1,547.38 Cr (+56.32% YoY)
EPS (Q1)Rs. 3.65 (+47.18% YoY)
Market capRs. 150,607.18 Cr
CMPRs. 354.95

Quarter Snapshot

Tata Capital delivered a strong quarter with PAT up 56% YoY, NIM expanding 309 bps YoY, and asset quality improving. However, financing revenue growth of 14.7% moderated versus the 18-20% target, and QoQ NIM compression from rising finance costs warrants monitoring.

Key Investment Insights

Key Positives

  • PAT attributable to owners surged 56.32% YoY to Rs.1,547.38 Cr
  • Net interest income grew 24.59% YoY to Rs.3,570.95 Cr, with NII margin expanding 309 bps YoY to 40.48%
  • Asset quality improved: GNPA fell to 2.45% from 2.62% YoY, NNPA to 1.07% from 1.24% YoY
  • Provision coverage ratio improved to 56.99% from 53.44% YoY
  • Impairment on financial instruments declined 25.34% YoY to Rs.678.35 Cr
  • Cost-to-income ratio improved to 36.37% from 36.81% YoY and sequentially from 38.26% in Q4FY26
  • Capital adequacy ratio remained strong at 18.46%

Risk Factors

  • Financing segment revenue growth of 14.7% YoY trailed management's 18-20% AUM growth guidance for FY27, indicating potential slowdown in loan book growth
  • NII margin compressed QoQ from 42.61% in Q4FY26 to 40.48% in Q1FY27 as finance costs rose 8.8% QoQ vs interest income growth of 6.0% QoQ
  • Operating expenses grew 21.4% YoY, outpacing revenue growth of 15.1% YoY, though NII growth offset the impact
  • Employee costs and other expenses grew 19.5% and 21.6% YoY respectively, indicating cost pressures
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now